Valion Bio, Inc.
For the period ended Dec 31, 2024. Filed Mar 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 21, 2025
VBIO$0.54+6.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Cash Flows
(in thousands)
| Years Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities | ||
| Net loss | $(5,655) | $(8,244) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Stock based compensation | 229 | 271 |
| Depreciation | 3 | 8 |
| Amortization of right-of-use asset | 349 | 174 |
| Reserve for inventory obsolescence | 354 | 32 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | 105 | (67) |
| Inventory | 83 | 75 |
| Prepaid expenses and other current assets | 78 | (92) |
| Accounts payable | (588) | (610) |
| Accrued expenses | (348) | 103 |
| Lease liabilities | (369) | (161) |
| Other assets | 34 | — |
| Net cash used in operating activities | (5,725) | (8,511) |
| Cash flows from investing activities | ||
| Acquisition of property and equipment | — | (118) |
| Net cash used in investing activities | — | (118) |
| Cash flows from financing activities | ||
| Proceeds from issuance of common stock, net of issuance costs | 4,381 | 8,507 |
| Offering costs in advance of sale of common stock | (49) | — |
| Net cash provided by financing activities | 4,332 | 8,507 |
| Net decrease in cash and cash equivalents | (1,393) | (122) |
| Cash and cash equivalents | ||
| Beginning of period | 3,395 | 3,517 |
| End of period | $2,002 | $3,395 |
| Supplemental disclosure on noncash financing activities | ||
| Issuance of common stock warrant | $70 | $363 |
| Deferred offering costs charged to additional paid-in-capital | $— | $584 |
| Write-off of ROU asset and lease liability | $290 | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.